↓ Skip to main content

Tissue-Protective Cytokines

Overview of attention for book
Cover of 'Tissue-Protective Cytokines'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Erythropoietin and Engineered Innate Repair Activators
  3. Altmetric Badge
    Chapter 2 Epo and Non-hematopoietic Cells: What Do We Know?
  4. Altmetric Badge
    Chapter 3 Tissue-Protective Cytokines: Structure and Evolution
  5. Altmetric Badge
    Chapter 4 The Regenerative Activity of Interleukin-6
  6. Altmetric Badge
    Chapter 5 Brain Ischemic Injury in Rodents: The Protective Effect of EPO
  7. Altmetric Badge
    Chapter 6 Experimental Traumatic Spinal Cord Injury
  8. Altmetric Badge
    Chapter 7 Erythropoietin as a Neuroprotectant for Neonatal Brain Injury: Animal Models
  9. Altmetric Badge
    Chapter 8 Evaluating Effects of EPO in Rodent Behavioral Assays Related to Depression
  10. Altmetric Badge
    Chapter 9 Erythropoietin and Cytoprotective Cytokines in Experimental Traumatic Brain Injury
  11. Altmetric Badge
    Chapter 10 Therapeutic efficacy of erythropoietin in experimental autoimmune encephalomyelitis in mice, a model of multiple sclerosis.
  12. Altmetric Badge
    Chapter 11 Deciphering the Intracellular Signaling of Erythropoietin in Neuronal Cells
  13. Altmetric Badge
    Chapter 12 Assessment of Allodynia Relief by Tissue-Protective Molecules in a Rat Model of Nerve Injury-Induced Neuropathic Pain
  14. Altmetric Badge
    Chapter 13 Intra-epidermal Nerve Fibers Density and Nociception in EPO-Treated Type 1 Diabetic Rats with Peripheral Neuropathy
  15. Altmetric Badge
    Chapter 14 ARA290 in a Rat Model of Inflammatory Pain
  16. Altmetric Badge
    Chapter 15 In Vivo Angiogenic Activity of Erythropoietin
  17. Altmetric Badge
    Chapter 16 Photoreceptor Degeneration in Mice: Adeno-Associated Viral Vector-Mediated Delivery of Erythropoietin
  18. Altmetric Badge
    Chapter 17 Myocardial Infarction: Cardioprotection by Erythropoietin
  19. Altmetric Badge
    Chapter 18 Using Plethysmography to Determine Erythropoietin’s Impact on Neural Control of Ventilation
  20. Altmetric Badge
    Chapter 19 Cerebral malaria: protection by erythropoietin.
Attention for Chapter 10: Therapeutic efficacy of erythropoietin in experimental autoimmune encephalomyelitis in mice, a model of multiple sclerosis.
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (86th percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

blogs
1 blog
twitter
2 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
15 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Therapeutic efficacy of erythropoietin in experimental autoimmune encephalomyelitis in mice, a model of multiple sclerosis.
Chapter number 10
Book title
Tissue-Protective Cytokines
Published in
Methods in molecular biology, January 2013
DOI 10.1007/978-1-62703-308-4_10
Pubmed ID
Book ISBNs
978-1-62703-307-7, 978-1-62703-308-4
Authors

Ilaria Cervellini, Pietro Ghezzi, Manuela Mengozzi

Abstract

Erythropoietin (EPO) has neuroprotective effects in many models of damage and disease of the nervous system where neuroinflammation plays a substantial role, including experimental autoimmune encephalomyelitis (EAE), the animal model of multiple sclerosis (MS). Since the first pioneering studies, in which EPO was shown to protect rats with acute EAE mainly by inhibiting inflammation, many other studies have pointed out other mechanisms of protection, including oligodendrogenesis and inhibition of axonal damage.Here we review the preclinical studies in which EPO has shown therapeutic efficacy in several models of EAE in mice and rats. Moreover, we report in detail the protocol to administer EPO to mice with myelin oligodendrocyte glycoprotein (MOG)-induced chronic progressive EAE, and a representative result. In this model, EPO inihibits the clinical score of the disease when administered according to a preventive but also to a therapeutic schedule, and therefore at disease onset, suggesting that it might not only inhibit inflammation but also actively stimulate repair.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 1 7%
Unknown 14 93%

Demographic breakdown

Readers by professional status Count As %
Researcher 3 20%
Student > Ph. D. Student 3 20%
Student > Doctoral Student 3 20%
Professor > Associate Professor 2 13%
Student > Master 1 7%
Other 2 13%
Unknown 1 7%
Readers by discipline Count As %
Medicine and Dentistry 5 33%
Agricultural and Biological Sciences 4 27%
Neuroscience 3 20%
Biochemistry, Genetics and Molecular Biology 1 7%
Unknown 2 13%

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 July 2014.
All research outputs
#985,426
of 8,087,098 outputs
Outputs from Methods in molecular biology
#282
of 5,759 outputs
Outputs of similar age
#15,402
of 117,212 outputs
Outputs of similar age from Methods in molecular biology
#2
of 25 outputs
Altmetric has tracked 8,087,098 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,759 research outputs from this source. They receive a mean Attention Score of 1.9. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 117,212 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 25 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.